ArticleBMC primary care2025
Identification and evaluation of drug-related problems in community pharmacy in Turkey: a descriptive prevalence study.
Article in BMC primary care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Impact of clinical pharmacist interventions on drug-related problems in hospitalised patients with renal dysfunction: a quasi-experimental study.Scientific reports · 2026Article
- Construction, operations, and sustainability of maternal and child health pharmacy clinics in China: a national multicenter cross-sectional survey.BMC health services research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCommunity pharmacies (CPs) are key healthcare providers, playing a significant role in optimizing drug therapy and preventing drug-related problems (DRPs). This study aims to assess the prevalence, characteristics, and related factors of DRPs in Turkish patients in the community pharmacy setting.
methodsA cross-sectional, prospective study was conducted between December 2023 and December 2024 in a community pharmacy. A total of 100 patients were included after excluding those with incomplete data. DRPs were evaluated using the PCNE V9.1 classification system, while Medication Adherence Report Scale (MARS) and Medication Regimen Complexity Index (MRCI) were used to assess adherence and regimen complexity.
resultsA total of 162 DRPs were identified, with an average of 1.6 DRPs per patient. DRPs were significantly associated with factors such as higher body mass index (p = 0.005), polypharmacy (p < 0.001), use of antidiabetic (p < 0.001) and antihypertensive medications (p = 0.005), and a higher number of comorbidities (p = 0.005). No significant relationship was observed between medication adherence and DRPs (p > 0.05). DISCUSSION: This study is among the first in Türkiye to evaluate DRPs in chronic disease management within a community pharmacy setting. The findings highlight the importance of clinical pharmacists in identifying and managing DRPs and suggest the need for integrated interventions in healthcare teams to improve patient outcomes and medication safety.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.